- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06093516
The ARUTIS Study (Anglia Ruskin University Trial of the Intuitive System) (ARUTIS)
The ARUTIS Study (Anglia Ruskin University Trial of the Intuitive System) A Single-centre, Double-masked Randomised Controlled Crossover Trial of Precision Tinted Lenses for Visual Stress
The goal of this double-masked randomised controlled trial (RCT) is to assess the symptoms of visual stress (VS), reading speed and changes in behaviour / academic performance, when wearing optimal Precision Tinted Lenses compared to sub-optimal Precision Tinted Lenses (PTLs). In participants ages 9-18 years.
Participants, parents and researchers will be masked until the end of the trial.
Participants will be randomised into two groups A and B. 50% of participants will receive the optimal PTL where the other 50% will receive the sub-optimal PTL.
Participants will be asked to wear the PTLs for one month. Followed by one month of no wear. After which, participants will receive the second pair of PTLs to wear for one month.
Participants will need to fill out a symptom dairy everyday from the day of recruitment until the end of the trial. A symptom questionnaire will need to be filled out as baseline at recruitment and the end of each month of wear. An academic behaviour survey will also need to be filled out at baseline by parents and teachers at recruitment and the end of each month of wear.
At the end of the three months unmasking will occur and participants will be given the PTL that demonstrate the greatest reduction in VS.
Study Overview
Detailed Description
The ARUTIS study is a double-masked randomised controlled trial (RCT) having a double-masked crossover (AB/BA) design. The study aims to assess the symptoms of visual stress (VS), reading speed and changes in behaviour / academic performance, when wearing optimal Precision Tinted Lenses compared to sub-optimal Precision Tinted Lenses (PTL). The PTLs will be prescribed by the Intuitive System.
A total of 120 participants aged 9-18 years with symptoms of VS will be recruited from the Anglia Ruskin University eye clinic. Participants will be randomised into either Group 1 (receiving the two interventions A (optimal tint) and B (sub-optimal) in the order AB) or Group 2 (receiving the two interventions in the order BA).
The initial pair of PTLs will be given to participants for a one-month wearing period. Subsequently, a one-month washout period is observed, after which participants receive the second pair of PTLs for one-month. Participants are required to fill out a symptom diary daily. A symptom questionnaire will need to be filled out as baseline at recruitment and the end of each month of wear. An academic behaviour survey will also need to be filled out at baseline by parents and teachers at recruitment and the end of each month of wear. Following the three months, a head-to-head comparison and unmasking will occur.
Participants will be given the Precision Tinted Lenses that demonstrate the greatest reduction in VS. The study will combine quantitative and qualitative data collection. The primary outcome measure is comparing symptom scores with questionnaires and symptom diaries reported under two different treatment conditions. The secondary outcome measures will be evaluated. in two ways: change in reading speed and results from academic behaviour surveys.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Zahra Ramsahye
- Phone Number: 07411505276
- Email: zk208@pgr.aru.ac.uk
Study Locations
-
-
-
Cambridge, United Kingdom, RM2 6DH
- Recruiting
- Anglis Ruskin University
-
Contact:
- Zahra Ramsahye
- Phone Number: 07411505276
- Email: zk208@pgr.aru.ac.uk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 9-18y.
- Meet diagnostic indicators for visual stress (see below)
- Consent (parent and participant to attend for optometric testing and participate in research.
- Do not anticipate moving from the area in the next 3 months
Diagnostic indicators for visual stress
At least three of the following six typical symptoms:
- Words Move
- Words Merge
- Patterns or shadows in text (e.g., "rivers")
- Text seems to stand out in 3-D above the page
- Words or letters fade or darken
- Discomfort with certain artificial lights and flicker
And "At least two of the following three signs from investigations:
- Voluntary unprompted use of an overlay for 3 months or more
- Overlay improves performance at the WWRT BY ≥15%
- PGT result >3 with mid spatial frequency grating.
Exclusion Criteria:
- History of wearing precision tinted lenses.
- Ocular pathology, systemic pathology that is likely to worsen in the timescale of the study or cause transient blur (e.g., diabetes) or photosensitive epilepsy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Optimal Precision Tinted Lenses (PTL)
|
Tinted coloured lenses with UV protection within spectacle frames with the intension to help reduce the symptoms of Visual stress.
|
|
Experimental: Sub-Optimal Precision Tinted Lenses (PTL)
The sub-optimal colour will be chosen as a colour of similar saturation to the optimal colour but differing in u'v' colour space by 0.07. Two colours of equal radial distance from the optimal colour will be considered. The colour that shares the name of the optimal colour or appears most similar will be chosen. After colorimetry, participants will choose a spectacle frame. Two pairs of PTLs will be made up by the manufacturing opticians, one to the optimal colour and the other to a slightly sub-optimal colour. |
Tinted coloured lenses with UV protection within spectacle frames with the intension to help reduce the symptoms of Visual stress.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparing symptom scores with symptom diaries reported under the two different treatment conditions
Time Frame: 3 months
|
Participants will be requiured to fill out a daily diary from day of recruitment to the end of the trial.
|
3 months
|
|
Comparing symptom scores with questionnaires reported under the two different treatment conditions.
Time Frame: 3 months
|
Participants will be required to fill out symptom questionnaires at baseline and at the end of each month wear.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Identify the change in reading speed for participants (if any) when wearing PTLs, by analysing the results of the Wilkins Rate of Reading test (WRRT).
Time Frame: 3 months
|
Participants will be required to perform a WRRT at baseline and at the collection of each PTLs. A WRRT will also be performed at the unmasking stage to compare both PTLs. |
3 months
|
|
Identify the academic/behavioural change (if any) in participants when wearing PTLs, by analysing a survey completed by parents/guardians and teachers.
Time Frame: 3 months
|
Parents/ teachers will be required to fill out the the academic/behavioural survey at baseline and at the end of each month wear.
|
3 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- ETH2223-7100
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
Data will be available after the trial has been completed. Which will be in approximately 12 months.
Data will be available for as long as necessary.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Visual Stress
-
Meir Medical CenterTel Aviv UniversityWithdrawn
-
University Hospital, Clermont-FerrandRecruitingOccupational Stress | Validation | Visual Analogue ScaleFrance
-
University of UlsterCompletedVisual Stress | Meares-Irlen Syndrome | Reading DifficultiesUnited Kingdom
-
Samsung Medical CenterSamsung ElectronicsUnknownStress, Psychological | Motion Sickness | Visual FatigueKorea, Republic of
-
US Department of Veterans AffairsCompletedPost-Traumatic Stress DisorderUnited States
-
Xuanwu Hospital, BeijingNot yet recruitingVisual Field Loss | Visual Field Defects
-
Brigham and Women's HospitalCompletedIncidental Findings | Visual Attention | Visual Search | Hybrid SearchUnited States
-
University of California, San FranciscoNational Eye Institute (NEI)CompletedRepetitive Transcranial Magnetic Stimulation | Visual Attention | Visual Cortical PlasticityUnited States
-
Weill Medical College of Cornell UniversityCompletedIntraocular Pressure | Visual Acuity | Visual DisturbanceUnited States
-
Stanford UniversityEnrolling by invitationGlaucoma | Visual Fields | Eye Disorders | Visual Field TestsUnited States
Clinical Trials on Tinted Lenses
-
City, University of LondonCompletedVision Disorders | Reading DisabilitiesUnited Kingdom
-
University of UlsterCompletedVisual Stress | Meares-Irlen Syndrome | Reading DifficultiesUnited Kingdom
-
University of UtahMayo Clinic; Northwell Health; Brigham and Women's Hospital; Axon Optics, LLCTerminated
-
University of OklahomaDean A. McGee Eye InstituteNot yet recruiting
-
University of Alabama at BirminghamRecruitingConcussion, Mild | Photophobia | Contact LensUnited States
-
University of ArizonaNational Heart, Lung, and Blood Institute (NHLBI)Not yet recruiting
-
Cristina Fernandez PerezUnknownSatisfaction | Product Quality
-
Rassoul Akram HospitalCompletedGlaucoma | CataractIran, Islamic Republic of
-
University of VirginiaJohnson & Johnson Vision Care, Inc.CompletedAstigmatismUnited States
-
Cornea and Laser Eye InstituteActive, not recruitingKeratoconus | Corneal Ectasia | Irregular Astigmatism | Aberration, Corneal Wavefront | Wavefront Aberration, Corneal | Pellucid Marginal Corneal Degeneration | KeratoglobusUnited States